Merger activity decreased with two new deals announced and one deal closing. You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) that automatically updates itself during market hours.
There were three new deals announced in the Deals in the Works section.
Deal Statistics:
Total Number of Deals Closed in 2019 | 190 |
Total Number of Deals Not Completed in 2019 | 9 |
Total Number of Pending Deals | |
Cash Deals | 48 |
Stock Deals | 22 |
Stock & Cash Deals | 5 |
Special Conditions | 5 |
Total Number of Pending Deals | 80 |
Aggregate Deal Consideration | $1.35 trillion |
New Deals:
Deal Updates:
Closed Deals:
Top 10 deals with largest spreads:
Symbol | Announced Date | Acquiring Company | Closing Price | Last Price | Closing Date | Profit | Annualized Profit |
---|---|---|---|---|---|---|---|
PACB | 11/01/2018 | Illumina, Inc. (ILMN) | $8.00 | $5.24 | 03/31/2020 | 52.67% | 208.97% |
S | 04/29/2018 | T-Mobile US, Inc. (TMUS) | $7.92 | $5.2 | 01/31/2020 | 52.34% | 597.02% |
GNW | 10/23/2016 | China Oceanwide Holdings Group Co., Ltd. (N/A) | $5.43 | $4.36 | 03/31/2020 | 24.54% | 97.36% |
ABDC | 08/13/2019 | Crescent Capital BDC, Inc. (N/A) | $11.02 | $9.19 | 12/31/2019 | 19.91% | 7268.23% |
FIT | 11/01/2019 | Google LLC (N/A) | $7.35 | $6.48 | 06/30/2020 | 13.43% | 26.78% |
SORL | 11/29/2019 | Ruili International Inc. (N/A) | $4.72 | $4.44 | 06/30/2020 | 6.31% | 12.58% |
MLNX | 03/11/2019 | NVIDIA Corporation (NVDA) | $125.00 | $117.86 | 03/31/2020 | 6.06% | 24.03% |
AMTD | 11/25/2019 | The Charles Schwab Corporation (SCHW) | $52.39 | $50.36 | 12/31/2020 | 4.02% | 4.00% |
YTRA | 07/17/2019 | Ebix, Inc. (EBIX) | $3.27 | $3.14 | 12/31/2019 | 3.98% | 1453.03% |
FSBC | 12/19/2019 | Evans Bancorp, Inc. (EVBN) | $17.80 | $17.12 | 06/30/2020 | 3.97% | 7.92% |
List of all pending deals:
Disclaimer: I hold long positions in Sprint (S), Mellanox Technologies (MLNX) and Pacific Biosciences of California (PACB). Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.
Connect with me on LinkedIn: http://www.linkedin.com/in/asifsuria or follow me on Twitter@asifsuria